Molecular structure of Resibufogenin, CAS Number: 465-39-4
Resibufogenin (CAS 465-39-4)
See product citations (2)
Application:
Resibufogenin is a specific inhibitor of Na+/K+-ATPase
CAS Number:
465-39-4
Purity:
≥98%
Molecular Weight:
384.5
Molecular Formula:
C24H32O4
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
Available in US only.
Available in US only.
* Refer to Certificate of Analysis for lot specific data.
QUICK LINKS
Ordering Information
Product Citations
Description
Technical Information
Safety Information
SDS & Certificate of Analysis
Resibufogenin has a specific Na+/K+-ATPase inhibitor.
Resibufogenin (CAS 465-39-4) References
- Effects of resibufogenin from toad venom on isolated Purkinje fibers. | Xie, JT., et al. 2000. Am J Chin Med. 28: 187-96. PMID: 10999437
- Resibufogenin corrects hypertension in a rat model of human preeclampsia. | Vu, H., et al. 2006. Exp Biol Med (Maywood). 231: 215-20. PMID: 16446498
- Resibufogenin administration prevents oxidative stress in a rat model of human preeclampsia. | Uddin, MN., et al. 2012. Hypertens Pregnancy. 31: 70-8. PMID: 21174582
- Novel microbial transformation of resibufogenin by Fusarium solani. | Xin, XL., et al. 2011. J Asian Nat Prod Res. 13: 831-7. PMID: 21830888
- Separation and determination of resibufogenin and cinobufagin in Chansu using reversed-phase liquid chromatography with γ-cyclodextrin as mobile-phase modifier. | Xing, J., et al. 2012. J Sep Sci. 35: 1884-92. PMID: 22623502
- Isolation and identification of phase I metabolites of resibufogenin in rats. | Zhu, ZT., et al. 2013. Xenobiotica. 43: 479-85. PMID: 23153055
- Biotransformation of resibufogenin by Actinomucor elegans. | Mou, LY., et al. 2014. J Asian Nat Prod Res. 16: 623-8. PMID: 24911667
- Resibufogenin Induces G1-Phase Arrest through the Proteasomal Degradation of Cyclin D1 in Human Malignant Tumor Cells. | Ichikawa, M., et al. 2015. PLoS One. 10: e0129851. PMID: 26121043
- Resibufogenin Suppresses Triple-Negative Breast Cancer Angiogenesis by Blocking VEGFR2-Mediated Signaling Pathway. | Yang, T., et al. 2021. Front Pharmacol. 12: 682735. PMID: 33995111
- Resibufogenin, one of bufadienolides in toad venom, suppresses LPS-induced inflammation via inhibiting NF-κB and AP-1 pathways. | Gao, Y., et al. 2022. Int Immunopharmacol. 113: 109312. PMID: 36252491
Inhibitor of:
Sodium/Potassium-ATPase Protein.Activator of:
Na+ CP type IIα, Na+/K+-ATPase α2, Na+/K+-ATPase α3, and Na+/K+-ATPase α4.Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Resibufogenin, 10 mg | sc-202788 | 10 mg | $315.00 | |||
| US: Only available in the US | ||||||